During the past decade, Universitätsklinikum Magdeburg A.ö.R., Universitätsaugenklinik conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Magdeburg A.ö.R., Universitätsaugenklinik" are "Diabetic Macular Edema" (2 trials), "Corneal Edema" (1 trials), "Fuchs' Endothelial Dystrophy" (1 trials), "Myopia, Progressive" (1 trials) and "Primary Open Angle Glaucoma (POAG)" (1 trials). Many other conditions were trialed in "Universitätsklinikum Magdeburg A.ö.R., Universitätsaugenklinik" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Magdeburg A.ö.R., Universitätsaugenklinik" are "Device" (3 trials), "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (2 trials), "Sham Procedure" (2 trials), "ARGOS-IO Sensor Pressure System" (1 trials), "ARGOS-IO system" (1 trials) and "Aflibercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Magdeburg A.ö.R., Universitätsaugenklinik" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Magdeburg A.ö.R., Universitätsaugenklinik". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Universitätsklinikum Magdeburg A.ö.R., Universitätsaugenklinik, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Magdeburg A.ö.R., Universitätsaugenklinik, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".